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Many compensatory mechanisms exit in hemorrhagic shock (HS). To characterize the
eﬃcacy of the new artiﬁcial oxygen carrier, liposome-encapsulated hemoglobin (LHb), HS
was induced by withdrawing 20% of the total blood volume from rats. Rats received one of
ﬁve interventions: LHb resuscitation (LHb-G, n ¼ 7), normal saline (Saline-G, n ¼ 7), shed
autologous blood (SAB-G, n ¼ 7), volume expander of 5% albumin (Albumin-G, n ¼ 7), or
no treatment (Sham-G, n ¼ 7). Heart rate variability (HRV) indices were measured, including
low frequency (LF, 0.10–0.60Hz), high frequency (HF, 0.60–2.00Hz), and the ratio of LF to
HF (LF/HF). LF and LF/HF following HS were lower in the LHb-G and SAB-G groups
when compared with the Saline-G, Albumin-G and Sham-G groups. LF and LF/HF following
HS in the LHb-G group were comparable with that of the SAB-G group. These data
demonstrate that HS-induced changes can be attenuated by resuscitation with LHb as well as
SAB. LHb could be used as a substitute for blood transfusion for HS.
(J Arrhythmia 2010; 26: 189–198)
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Introduction
Many compensatory mechanisms participate in
the response to hemorrhagic shock, including neuro-
hormonal factors1–3) mediated by pressure receptors
and chemoreceptors,4–6) and increases in sympathetic
nervous system activity. Heart rate variability (HRV)
is a well known index that reﬂects the autonomic
control of the heart,7,8) but changes in HRV in
response to hemorrhagic shock remain unclear.
Hemoglobin (Hb)-based O2 carriers (HBOCs)
have been developed as a substitute for red blood
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cells and some of them are currently in clinical trials
as oxygen therapeutics.9–11) HBOCs are classiﬁed
into two categories; one is acellular Hb (polymerized
Hb, cross-linked Hb, PEG-modiﬁed Hb) and the
other is cellular Hb (liposome-encapsulated Hb
hemoglobin vesicles). It has been reported that the
acellular Hbs have a pressor eﬀect on peripheral
vessels as nitric oxide (NO) scavengers, and sub-
sequent harmful eﬀects on the microcirculationm,
because the acellular Hbs have a high aﬃnity to NO
and thereby they combine with NO in the vessel
lumen and/or in the interstitial space after extrava-
sation of the acellular Hb.12,13) In contrast, the
cellular Hbs have lipid bilayer membranes (lip-
osome) that prevent direct contact with blood
components and endothelium so that cellular Hbs
can attenuate this pressor eﬀect of acellular Hbs.14)
Recently, the use of an artiﬁcial oxygen carrier
composed of polyethylenglycol-modiﬁed liposome-
encapsulated hemoglobin (LHb), which is classiﬁed
as the cellular Hbs, has been demonstrated to be
beneﬁcial in the treatment of hemorrhagic shock in
animal models.15–17) Further, this artiﬁcial oxygen
carrier may signiﬁcantly aﬀect changes in HRV
during hemorrhagic shock through its salutary eﬀect
on the autonomic nervous system.
Therefore, the goal of the present study was to
investigate the inﬂuence of hemorrhagic shock on
autonomic nervous system activity assessed by HRV
and to characterize the therapeutic eﬃcacy of the
newly developed artiﬁcial oxygen carrier, LHb, in an
animal model of hemorrhagic shock.
Methods
All animal procedures were conducted in accord-
ance with guidelines published in the Guide for the
Care and Use of Laboratory Animals (DHEW
publication NIH 85-23, revised 1996, Oﬃce of
Science and Health Reports, DRR/NIH, Bethesda,
MD, USA). The study protocol was approved by the
Committee on Animal Research of the National
Defense Medical College.
1. Materials and experimental preparation
Experiments were performed using 35 male
Sprague Dawley rats (weight range, 270–350 g;
mean weight, 310 g; Tokyo Laboratory Animal
Science, Tokyo, Japan). All rats were housed in
cages and provided with food and water ad libitum in
a temperature-controlled room on a 12-hr dark/light
cycle. Rats were anesthetized by intraperitoneal
administration of sodium pentobarbital (50mg/kg
body weight) and then allowed to stabilize under
spontaneous respiration on a heating blanket to
maintain a body temperature 37–38 C. Needle-type
electrodes were inserted into the subcutaneous
area in both the front and hind limbs in order to
continuously record the electrocardiogram (ECG).
The left femoral artery and vein were cannulated
with polyethylene indwelling needles (27G, Terumo,
Co., Tokyo, Japan). Needles were placed into the
femoral artery and connected to a ﬂuid-ﬁlled
manometer (ADInstrument BPump Utah Medical
Products Inc., Utah, USA) to monitor blood pressure.
ECG and blood pressure were continuously moni-
tored and recorded using a commercial laboratory
catheter system (RMC-3100, CardioMaster, Nihon-
Koden Inc., Tokyo, Japan).
LHb1) was provided by Terumo Corp. (Tokyo,
Japan). Features of LHb are brieﬂy summarized as
follows: LHb was made of stroma-free hemoglobin
solution, which was obtained from outdated human
red blood cells and encapsulated by liposomes
(diameter, 220 nm). The surfaces of encapsulated
liposomes were modiﬁed with 5-kDa polyethylen-
glycol in order to attenuate aggregation. LHb was
diluted with saline to 6 g/dl Hb in concentration. The
P50 (a measure of O2 tension when the Hb binding
sites are 50% saturated) was adjusted to 40–50
mmHg by adding inositol hexaphosphate.18)
1) Hemorrhagic shock resuscitated with LHb,
normal saline and shed autologous blood (SAB)
The arterial line was used to induce hemorrhagic
shock by withdrawing 20% of systemic blood
volume over a period of 2min from the femoral
artery. Systemic blood volume was estimated at
5.6% of total body weight (56ml/kg). Five minute
later, the same volume of LHb (LHb group, n ¼ 7),
normal saline (0.9% NaCl; Saline group; n ¼ 7) and
SAB (SAB group, n ¼ 7) was infused through the
femoral vein for resuscitation. Seven rats did not
receive resuscitative treatment (Sham group).
2) Hemorrhagic shock resuscitated with either
LHb or volume expander
In order to separately evaluate the eﬀect of LHb’s
oxygen carrying and volume expanding properties
during hemorrhagic shock, the following experiment
was additionally conducted. The arterial line was
also used to induce hemorrhagic shock by with-
drawing 20% of systemic blood volume over a 2min
period from the femoral artery. Five minutes later,
the same volume of a 5% albumin volume expander
(Albumin group, n ¼ 7) was infused through the
femoral vein for resuscitation. The Albumin group
was compared with the LHb-resuscitated group
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prepared using the same method as previously
described (n ¼ 7).
2. Measurement of the HRV indices and exper-
imental protocol
RR intervals were transferred to a personal com-
puter, and HRV indices were measured with com-
mercialized software (MemCalc/Tarawa, Suwa
Trust Inc., Tokyo, Japan) based on the RR intervals
of normal sinus beats obtained from the ECG
throughout the entire study period as previously
reported19) and sampling frequency of ECG for
measuring HRV indices was 1000Hz. For the
frequency domain analysis, online analysis was
performed for ﬁve consecutive RR intervals using
the modiﬁed Maximum Entropy Method. Low
frequency spectra (LF, 0.10–0.60Hz), and high
frequency spectra (HF, 0.60–2.00Hz) were continu-
ously calculated. Thereafter, these values were
averaged over the subsequent 5min from time points
that are described later. The ratio of low frequency
spectra and high frequency spectra was also meas-
ured as the LF/HF ratio. Heart rate, blood pressure,
and HRV indices were measured immediately before
hemorrhage (Pre), immediately after hemorrhage
(After bleeding), immediately after resuscitation with
LHb, normal saline, SAB or 5% albumin infusion
(Just after infusion), and 15min, 30min, 45min and
60min after resuscitation as shown in Figure 1.
All these experimental procedures were performed
during day time between 09:00 and 17:00 (light
cycle).
3. Statistics
Data are expressed as mean SEM if not other-
wise indicated. Student’s t-test was used to compare
heart rate, blood pressure, and HRV indices between
two groups. Data among three groups were com-
pared by ANOVA with Scheﬀe’s correction. Tem-
poral changes in each parameter were compared by
repeated calculation of ANOVA if not otherwise
indicated. P < 0:05 was considered to represent
statistical signiﬁcance.
Results
1. Hemorrhagic shock resuscitated with LHb,
normal saline and SAB compared with Sham group
Induction of hemorrhagic shock resulted in a
decrease in mean blood pressure to almost same
A) Before hemorrhage
C) Infusion of resuscitation fluid
B) Bolus withdrawing 20% of SBV
Figure 1
Typical real tracings of heart rate variability indices before hemorrhage (A), bolus withdrawing 20% of systemic
blood volume (SBV, B) and infusion of resuscitation ﬂuid (C).
LF: low frequency spectra, HF: high frequency spectra, LF/HF: LF/HF ratio
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degree around from 101 2mmHg to 35 2mmHg
in all four groups (Figure 2-A). Resuscitation resulted
in an abrupt increase in mean blood pressure to
80 8mmHg, 70 8mmHg and 101 5mmHg in
the LHb, Saline and SAB groups, respectively
(Figure 1-A). Animals in the Sham group showed
spontaneously gradual recovery in blood pressure
despite the absence of resuscitative interventions.
When the temporal change in mean blood pressure
was compared, mean blood pressure in LHb and
SAB groups tended to be higher than those of
the other two groups. There was no signiﬁcant
diﬀerence in shock-induced changes in heart rate
when comparing the three intervention groups
(Figure 2-B).
Temporal changes in HRV indices are shown in
Figures 3-A, B, C. Induction of hemorrhagic shock
resulted in signiﬁcant and similar increases in LF
spectra in all four groups (Figure 2-A). After resusci-
tation or spontaneous recovery, the value of the LF
spectra in both Saline and Sham groups gradually
and signiﬁcantly increased, whereas the value of the
LF spectra in the LHb and SAB group remained low.
As a result, the values of LF spectra at 60min after
resuscitation was signiﬁcantly lower in the LHb
and SAB groups than in the Sham and Saline
groups (0:04 0:01ms2/Hz, 0:02 0:01ms2/Hz
vs. 0:22 0:08ms2/Hz and 0:12 0:03ms2/Hz,
P < 0:05). Further, values of the HF spectra tended
to be higher in the LHb and SAB groups when
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Figure 2
Temporal changes in mean blood pres-
sure (mmHg; panel A) and heart rate
(beats/min; panel B) are illustrated in
hemorrhagic shock resuscitated with
polyethylenglycol-modiﬁed liposome-
encapsulated hemoglobin (LHb), nor-
mal saline (Saline) and shed autologous
blood (SAB), and also in hemorrhagic
shock without resuscitation (Sham
group).
LHb: LHb group, Saline: Saline group,
Sham: Sham group, SAB: SAB group,
Data are expressed as mean SEM,
Pre: values measured immediately be-
fore hemorrhage, After bleeding: values
measured immediately after hemor-
rhage, Just after infusion: values meas-
ured immediately after resuscitation
with each infusion, 15min, 30min,
45min and 60min are indicated as time
elapsed after resuscitation.
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compared with the Sham and Saline groups at most
time points, but this diﬀerence did not reach the level
of statistical signiﬁcance (Figure 3-B). The LF/HF
ratio after resuscitation tended to be lower in the
LHb and SAB groups when compared with the Sham
and Saline groups (Figure 3-C). Further, the LF/HF
ratio at 60min after resuscitation was signiﬁcantly
lower in the LHb and SAB groups than in the Sham
and Saline groups (0:05 0:01, 0:11 0:05 vs
0:60 0:27, 0:48 0:18, P < 0:05).
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Figure 3
Temporal changes in low frequency
spectra (LF, ms2/Hz; panel A), high
frequency spectra (HF ms2/Hz; panel
B), and LF/HF ratio (panel C) in
hemorrhagic shock resuscitated with
polyethylenglycol-modiﬁed liposome-
encapsulated hemoglobin (LHb), nor-
mal saline (Saline) and shed autologous
blood (SAB), and also in hemorrhagic
shock without resuscitation (Sham
group).
Format and abbreviations are identical
to those in Figure 2.
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2. Hemorrhagic shock resuscitated with volume
expander
To compare the eﬀect of volume expander with
that of LHb, the same data described above were
used for LHb group. Induction of hemorrhagic shock
resulted in a decrease in mean blood pressure to
almost same degree (from 100 3mmHg to 35 3
mmHg) in the two groups (LHb and Albumin
groups). In the LHb and albumin groups, resuscita-
tion resulted in an abrupt increase in mean blood
pressure to 80 8mmHg and 82 5mmHg, re-
spectively (Figure 4-A). There was no signiﬁcant
diﬀerence in shock-induced changes in heart rate
when comparing the two groups (Figure 4-B).
Temporal changes in HRV indices are shown in
Figures 5-A, B, C. The LF after resuscitation tended
to be lower in the LHb group than the Albumin
group. Further, the LF at 60min after resuscitation
was signiﬁcantly lower in the LHb group than in
the Albumin group (0:04 0:01 vs. 0:19 0:07,
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Figure 4
Temporal changes in mean blood pres-
sure (mmHg; panel A) and heart rate
(beats/min; panel B) are illustrated in
hemorrhagic shock resuscitated with
either polyethylenglycol-modiﬁed lip-
osome-encapsulated hemoglobin (LHb)
or volume expander of 5% albumin.
LHb: LHb group, Alb: Albumin group,
Data are expressed as mean SEM,
Pre: values measured immediately be-
fore hemorrhage, After bleeding: values
measured immediately after hemor-
rhage, Just after infusion: values meas-
ured immediately after resuscitation
with each infusion, 15min, 30min,
45min and 60min are indicated as time
elapsed after resuscitation.
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P < 0:05; Figure 5-A). Values of the HF spectra
tended to be higher in the LHb group when
compared with the Albumin group at most time
points, but this diﬀerence did not reach the level of
statistical signiﬁcance (Figure 5-B). The LF/HF ratio
after resuscitation tended to be lower in the LHb
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Figure 5
Temporal changes in low frequency
spectra (LF, ms2/Hz; panel A), high
frequency spectra (HF, ms2/Hz; panel
B), and LF/HF ratio (panel C) in
hemorrhagic shock resuscitated with
either polyethylenglycol-modiﬁed lip-
osome-encapsulated hemoglobin (LHb)
or volume expander of 5% albumin.
Format and abbreviations are identical
to those in Figure 4.
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group than the Albumin groups (Figure 5-C). In
addition, the LF/HF ratio at 60min after resuscita-
tion was signiﬁcantly lower in the LHb than in
the Albumin group (0:05 0:01 vs. 0:29 0:14,
P < 0:05).
Discussion
The present study demonstrates that induction of
hemorrhagic shock resulted in changes in autonomic
nervous system activity, as evaluated by HRV. The
LF spectra and LF/HF ratio increased during
spontaneous recovery from hemorrhagic shock
(Sham group), which is consistent with previous
reports of augmented sympathetic nervous system
activity in response to hemorrhagic shock.1–6) Fur-
ther, HRV changed during the recovery phase of
hemorrhagic shock without concomitant changes in
heart rate, which suggests that heart rate alone is not
a suitable proxy for sympathetic nervous system
activity, speciﬁcally, in the setting of 20% hemor-
rhagic shock recovery phase.
The changes in LF and LF/HF ratio in the Sham
group over the time period of the study also suggest
that these observations are the natural course of
HRV indices during the sublethal hemorrhage. The
marked increase in the LF and LF/HF ratio
immediately after bleeding indicates the presence
of a compensatory sympathetic surge in response to
prompt bleeding and cardiovascular collapse. Sub-
sequent and transient decrease in the LF and LF/HF
ratio took place due to stoppage of bleeding. Finally,
gradual increases of LF and LF/HF ratio have
continued over the recovery phase of bleeding
compensating for blood loss in order to maintain
blood pressure.
In general, HRV reﬂects sympathetic nervous
system or vagal activity.7,8) However, confounding
factors, such as respiration and/or anesthesia, may
alter the relationship between HRV and autonomic
nervous system activity. In this study, LF spectra and
LF/HF ratio changed during the recovery phase of
hemorrhagic shock despite use of general anesthesia
with spontaneous breathing. Thus, the power spectral
technique for measurement of HRV appears to be a
useful technique to assess changes in autonomic
nervous system activity during hemorrhagic shock
under general anesthesia without control respiration.
In addition, several compensatory responses in-
cluding both neural and humoral responses take
place after the signiﬁcant hemorrhagic shock.
Among these mechanisms, following compensatory
responses are considered (1) prompt increase in
cardiac contraction with and without the modiﬁca-
tion of peripheral vascular tone through changing
autonomic nervous activities, (2) humoral changes in
order to preserve intravascular volume and salt, and
(3) changes in the regional microcirculation to
regulate organ blood perfusion. These phenomena
were mainly caused by two pathways; one is
autonomic nervous system and another is hypothala-
mic-pituitary adrenal axis. These systems are sig-
niﬁcantly activated after hemorrhagic shock.20) The
relation between autonomic nervous system and
HRV indices has already been discussed earlier. In
the hypothalamic-pituitary adrenal axis, compensa-
tory activity of the rennin-angiotensin system occurs
after hemorrhagic shock. Among HRV indices, LF
has been inﬂuenced by rennin-angiotensin system
and the value of LF increase in accordance with
rennin-angiotensin system activation.21) Our obser-
vation of compensatory increase of LF after hemor-
rhagic shock in Sham and Saline groups (Figure 3)
agrees with the earlier report.
According to a well-accepted concept,20) heart
rate and HRV are physiologically correlated with
each other. However, this correlation could deteri-
orate in the case of the alteration or collapse of
cardiovascular system as occurs during hemorrhagic
shock. The dissociation of heart rate and HRV
immediately after bleeding in this study can be
explained by the impairment of the harmonic
relationship between heart rate and HRV due to
cardiovascular collapse. The large values of LF and
LF/HF ratio despite bradycardia immediately after
bleeding suggest that the heart and vessels could not
respond properly to the sympathetic drive. After the
treatments or even with no treatment (Sham group),
the heart and vascular system could begin to
gradually respond to the sympathetic drive.
Many previous reports indicate that acute bleed-
ings of 20% of total body blood causes signiﬁcant
hypotension up to the level of hemorrhagic shock.
According to the previous reports,23–27) a moderate
amount of rapid bleeding (ranging from 17% to
30%) can cause reversible hemorrhage shock that
is similar to the condition observed in this study.
In addition, as pointed out by Secher et al,23)
the relative bradycardia can occur during hemor-
rhage23,24) while tachycardia is considered as the
typical feature for acute hemorrhage. Transient and
reversible hypotension as well as relative bradycar-
dia observed in this study are in agreement with
these reports.
Experimental ﬁndings from the present study are
consistent with those from past studies. For example,
previous studies have reported that the LF spectra
increased in response to hemorrhagic shock, whereas
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there was no consistent change in the HF spectra.24)
In contrast, another study reported that the HF
spectra decreased in response to acute blood loss,
which suggests decreased vagal activity.28) Finally,
another group recently reported that the HRV is a
good indicator of the change in autonomic nervous
system activity during hemorrhage.29) In this report,
central volume in the body is well reﬂected the
changes in the HRV indices.
The present study demonstrated that treatment
with LHb as well as SAB signiﬁcantly attenuated
sympathetic nervous system activity during the
recovery phase of hemorrhagic shock. Indeed, the
LF spectra and LF/HF ratio during the recovery
phase of hemorrhagic shock were signiﬁcantly lower
in the LHb and SAB groups than in the Saline and
Sham groups. In addition, HF spectra tended to be
higher in the LHb group when compared with the
Sham, SAB and Albumin groups. These observa-
tions are consistent with conventional knowledge
regarding the physiology of hemorrhagic shock. For
example, increases in vagal activity can counteract
the hemodynamic changes associated with hemor-
rhagic shock,30–33) and increases in vagal activity and
decreases in sympathetic nervous system activity
occur during the recovery from hemorrhagic
shock.6,34)
The LF spectra and LF/HF ratio during the
recovery phase of hemorrhagic shock were signiﬁ-
cantly lower in the LHb group than in the Albumin
group. These observations suggest that volume
expander of 5% albumin alone could not attenuate
sympathetic nervous system activity during the
recovery phase of hemorrhagic shock. Similar to
SAB, LHb might have a volume-expansive eﬀect.
However, our results showed that volume expansion
alone did not attenuate sympathetic nervous system
activity so we presume that the oxygen carrying
capacity of LHb could cause attenuation of sympa-
thetic nervous system activity during the recovery
phase of hemorrhagic shock.
LHb has excellent oxygen-carrying capacity, and
its particle diameter is only 220 nm (nearly 30 times
smaller than a human red blood cell2)), allowing it
to easily penetrate into the microcirculation, even
during hemorrhagic shock which may induce vaso-
constriction. These characteristics allow improved
oxygen delivery to tissues and may also LHb to
modulate autonomic control of the heart during
hemorrhagic shock via its direct eﬀects on circu-
lation and its ability to inhibit chemo-reﬂex sensi-
tivity. Further study of the mechanisms by which
LHb modulates autonomic nervous system activity
during hemorrhagic shock would be of beneﬁt.
Study limitations: This study has several limita-
tions. We did not give liposome with the same
structure without oxygen carrying capacity to the
hemorrhagic shock rats. To clarify whether liposo-
mal capsules have volume-expansive eﬀect and
induce elevation of blood pressure, and then mod-
ulate autonomic nervous system activity during
hemorrhagic shock, liposomal capsules with the
same structure without oxygen carrying capacity
should be studied in the future. Lastly, we only used
the MemCalc system to measure HRV indices that is
modiﬁed maximum entropy method. We presume
that either Fast fourier transform or complex
demodulation method can be applied to our exper-
imental model.
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